SCHEMBL29535867

SCHEMBL29535867

CSc1ccc(Cc2cnn(C)c2C(F)(F)F)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC5A2 P31639 2/20 0.43
SLC6A4 P31645 6/20 0.40
SLC6A2 P23975 3/20 0.40
SLC6A3 Q01959 3/20 0.40
MPO P05164 1/20 0.37
CYP11B2 P19099 1/20 0.36
TBXA2R P21731 1/20 0.34
PTGER3 P43115 1/20 0.34
PTGER2 P43116 1/20 0.34
PTGDR Q13258 1/20 0.34
SLC5A1 P13866 1/20 0.33
MAOA P21397 1/20 0.32
TUBB4A P04350 1/20 0.32
TUBB P07437 1/20 0.32
TUBA3C P0DPH7 1/20 0.32
TUBA1B P68363 1/20 0.32
TUBA4A P68366 1/20 0.32
TUBB4B P68371 1/20 0.32
TUBB3 Q13509 1/20 0.32
TUBB2A Q13885 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12181546 0.71 MPO (0.42) MPOCYP11B2
SCHEMBL1842778 0.70 CYP11B2 (0.44) MPOCYP11B2
SCHEMBL4924021 0.70 MPO (0.44) MPOCYP11B2
SCHEMBL5263383 0.70 MPO (0.41) MPOCYP11B2
SCHEMBL29536485 0.70 SLC6A4 (0.41) SLC5A2SLC6A4SLC6A2SLC6A3TBXA2R
SCHEMBL29798879 0.68 SLC6A4 (0.42) SLC6A4SLC6A2SLC6A3TBXA2RPTGER3
SCHEMBL21092871 0.68 CYP11B2 (0.41) MPOCYP11B2
SCHEMBL9471608 0.66 SLC5A2 (0.44) SLC5A2SLC6A4SLC5A1
SCHEMBL13026656 0.66 SLC6A4 (0.56) SLC6A4SLC6A2SLC6A3MAOA
SCHEMBL2046936 0.63 TSHR (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3976053-A1 COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISEASE Avolynt (US) 2022-04-06 EP disclosed